The successful translation of 3D-printed microneedle (MN) technologies from laboratory research to widespread clinical and commercial use requires careful consideration of regulatory, manufacturing, and market-related factors. This chapter provides an overview of current market trends and growth patterns, highlighting emerging start-ups and commercially available microneedle products. Updated regulatory guidelines and frameworks are discussed, with particular attention to recent developments in regulatory pathways, including FDA guidance updates and evolving CE marking requirements. The chapter also examines the intellectual property landscape, reviewing recent patent filings and licensing trends that influence innovation and commercialization strategies. In addition, advances in manufacturing scale-up and quality assurance are explored, emphasizing process optimization, reproducibility, and compliance with regulatory standards. Overall, this chapter outlines the key challenges and opportunities shaping the commercialization of 3D-printed microneedle systems.